NCT06043154

Brief Summary

This study will investigate the link between the gut microbiota, the occurrence of the central adiposity phenotype, and the patients' fear to regain weight in anorexia nervosa.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
29mo left

Started Feb 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Feb 2024Sep 2028

First Submitted

Initial submission to the registry

September 4, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

February 22, 2024

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2028

Last Updated

November 14, 2025

Status Verified

November 1, 2025

Enrollment Period

4.6 years

First QC Date

September 4, 2023

Last Update Submit

November 13, 2025

Conditions

Keywords

microbiota, dysbiosis

Outcome Measures

Primary Outcomes (3)

  • Identification of gut microbiota biomarkers - composition

    Species-level taxonomic profile and functional potential of the gut microbiota generated by shotgun metagenomics performed on stool samples collected at inclusion, between those who express or not the central adiposity phenotype.

    At inclusion

  • Identification of gut microbiota biomarkers - diversity and richness

    α-diversity, β-diversity, richness in genes, richness in species and enterotype of the gut microbiota generated by shotgun metagenomics performed on stool samples collected at inclusion, between those who express or not the central adiposity phenotype

    At inclusion

  • Identification of gut microbiota biomarkers - metabolites

    Levels of Short Chain Fatty Acids (SCFAs) (acetate, propionate, butyrate, valerate, isobutyrate and isovalerate) produced by the gut microbiota estimated through gas chromatography-mass spectrometry on blood and stool samples collected at inclusion, between those who express or not the central adiposity phenotype.

    At inclusion

Secondary Outcomes (7)

  • Identification of the central adiposity phenotype

    At inclusion

  • Characterisation of gut microbiota biomarkers of patients with severe to extreme anorexia nervosa - composition

    At inclusion

  • Characterisation of gut microbiota biomarkers of patients with severe to extreme anorexia nervosa - diversity and richness

    At inclusion

  • Characterisation of gut microbiota biomarkers of patients with severe to extreme anorexia nervosa - metabolites

    At inclusion

  • Variation of the composition of the gut microbiota between admission and discharge

    At discharge, anticipated average 10 weeks

  • +2 more secondary outcomes

Study Arms (1)

Anorexia nervosa

EXPERIMENTAL
Other: Patients with severe to extreme anorexia nervosa admitted to hospital for refeeding

Interventions

Clinical and biological measurements, blood and stool sample collection

Also known as: Clinical and biological measurements, blood and stool sample collection
Anorexia nervosa

Eligibility Criteria

Age15 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen only, due to the high influence of sex hormones and the low sex ratio of men admitted at hospital for anorexia nervosa.
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Women
  • Over 15 years old and 3 months.
  • Admitted in the specialized department for eating disorders of CHU Nantes for refeeding.
  • With a diagnosis of anorexia nervosa at admission (restrictive or Binge-Eating-Purging type).
  • Body Mass Index at admission below 16 kilogram per square meter.
  • Written informed consent for patients over 18 years old/ oral informed consent from both the patient and a legal representative for patients under 18 years old.
  • Affiliated with French social security system or beneficiary from such system.

You may not qualify if:

  • Pregnant and breastfeeding women.
  • Who received a treatment with antibiotic/antifungal (other than local application) in the last three months.
  • Who had a weight gain in the last month (5% or more of the patient's weight at admission).
  • Under trusteeship or guardianship.
  • Not fluent in French
  • Who participate in another interventional study involving medication.
  • Patients for whom stool collection or body mass composition analysis (with Dual-energy X-ray absorptiometry) couldn't be done during the first week of hospitalisation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nantes University Hospital

Nantes, 44093, France

RECRUITING

MeSH Terms

Conditions

Anorexia NervosaDysbiosis

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Central Study Contacts

Marie GRALL-BRONNEC, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2023

First Posted

September 21, 2023

Study Start

February 22, 2024

Primary Completion (Estimated)

September 30, 2028

Study Completion (Estimated)

September 30, 2028

Last Updated

November 14, 2025

Record last verified: 2025-11

Locations